Methods and devices for the treatment of ocular conditions
First Claim
1. A method for instilling one or more bioactive agents into ocular tissue within an eye of a patient for the treatment of an ocular condition, the method comprising concurrently using at least two of the bioactive agent delivery methods (A)-(C):
- (A) implanting a sustained release delivery device comprising one or more bioactive agents in a posterior region of the eye so that it delivers the one or more bioactive agents into a vitreous humor;
(B) instilling one or more bioactive agents subretinally by direct injection or by implantation of a delivery device comprising one or more bioactive agents; and
(C) instilling one or more bioactive agents into the vitreous humor by direct injection or by iontophoresis.
0 Assignments
0 Petitions
Accused Products
Abstract
Featured is a method for instilling one or more bioactive agents into ocular tissue within an eye of a patient for the treatment of an ocular condition, the method comprising concurrently using at least two of the following bioactive agent delivery methods (A)-(C): (A) implanting a sustained release delivery device comprising one or more bioactive agents in a posterior region of the eye so that it delivers the one or more bioactive agents into the vitreous humor of the eye; (B) instilling (e.g., injecting or implanting) one or more bioactive agents subretinally; and (C) instilling (e.g., injecting or delivering by ocular iontophoresis) one or more bioactive agents into the vitreous humor of the eye.
-
Citations
20 Claims
-
1. A method for instilling one or more bioactive agents into ocular tissue within an eye of a patient for the treatment of an ocular condition, the method comprising concurrently using at least two of the bioactive agent delivery methods (A)-(C):
-
(A) implanting a sustained release delivery device comprising one or more bioactive agents in a posterior region of the eye so that it delivers the one or more bioactive agents into a vitreous humor; (B) instilling one or more bioactive agents subretinally by direct injection or by implantation of a delivery device comprising one or more bioactive agents; and (C) instilling one or more bioactive agents into the vitreous humor by direct injection or by iontophoresis. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20)
-
Specification